top of page
Oppenheimer Reiterates Outperform Rating for MongoDB (NASDAQ: MDB) Amid Strong Financial Performance

Oppenheimer Reiterates Outperform Rating for MongoDB (NASDAQ: MDB) Amid Strong Financial Performance

  • Oppenheimer reaffirmed its Outperform rating for MongoDB and raised its price target to $410.00 from $375.00, indicating strong analyst confidence in the software company.
  • MongoDB reported impressive Q1 fiscal 2027 results, with revenue reaching $687.62 million (a 25% year-over-year increase) and non-GAAP earnings per share of $1.32, both exceeding expectations.
  • The company's cloud database platform, Atlas, was a key growth driver, with its revenue growing 29% and contributing 75% of total revenue, leading to a positive net income of $4.40 million.

On May 29, 2026, analyst firm Oppenheimer confirmed its Outperform rating for MongoDB (NASDAQ: MDB). MongoDB is a software company that provides a popular database platform for developers and businesses. Oppenheimer also increased its price target for MongoDB to $410.00 from $375.00, signaling strong confidence in the company's future performance.

This positive outlook is supported by the company's recent financial success. As highlighted by Benzinga, MongoDB announced better-than-expected results for its first quarter of fiscal 2027. The company reported revenue of $687.62 million, a 25% increase from the previous year. Its non-GAAP earnings per share of $1.32 also surpassed analyst predictions.

A major factor in this growth is MongoDB's cloud database platform, Atlas. Revenue from Atlas grew by 29% and now makes up 75% of the company's total revenue. This strong performance from its main product contributed to a significant financial turnaround, with the company posting a positive net income of $4.40 million.

The company's financial health shows further improvement with its operating cash flow nearly doubling to $202.00 million. This metric shows the cash generated from normal business operations. Additionally, its remaining performance obligations grew 88% to $1.50 billion. This figure represents future revenue that is already under contract, indicating a strong sales pipeline.

Want to know when to buy this stock? Download the Stocks 2 Buy app or try the Web version

Group 82_edited.png

Forecast your chosen stock price with the Stock Sentiment Map

Comments

Share Your ThoughtsBe the first to write a comment.
Copy of Logo circular simple negro.png
bottom of page